BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 30525231)

  • 1. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 3. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
    De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
    Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol Inhibits Cell Proliferation, Migration, and Invasion via mir-410-3p/Transforming Growth Factor-β Receptor Type 2 (TGFBR2) Axis in Glioma.
    Li F; Li F; Chen W
    Med Sci Monit; 2020 Jan; 26():e919523. PubMed ID: 31960827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Zhao C; Ling X; Li X; Hou X; Zhao D
    Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
    Chen XB; Li W; Chu AX
    J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.
    Qu Y; Zhang H; Duan J; Liu R; Deng T; Bai M; Huang D; Li H; Ning T; Zhang L; Wang X; Ge S; Zhou L; Zhong B; Ying G; Ba Y
    Oncotarget; 2016 May; 7(22):33286-96. PubMed ID: 27120811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells.
    Ye Z; Zhao L; Li J; Chen W; Li X
    Int J Gynecol Cancer; 2015 Nov; 25(9):1574-81. PubMed ID: 26501435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.
    Zhou B; Guo W; Sun C; Zhang B; Zheng F
    Cell Death Dis; 2018 Jun; 9(6):706. PubMed ID: 29899418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.